The cellular activities of amphotericin B (AmB) used as Fungizone were compared with those of AmB complexed to either egg lecithin and glycocholate (Egam) or egg lecithin and deoxycholate (Edam). Under conditions in which leakage of K+ from erythrocytes and cultured L cells treated with Fungizone was almost complete, Egam and Edam containing concentrations of AmB severalfold greater than the concentration of AmB in Fungizone had no effect but retained the ability to decrease the level of retention of K+ in fungal cells.Analysis by absorption and circular dichroism spectroscopy demonstrated that when these formulations containing AmB at concentrations of less than 10-5 M were added to buffer, the AmB dissociated slowly as monomers from Egam or Edam and dissociated rapidly as a mixture of monomers and self-associated species from Fungizone. We propose that in Egam and Edam, the absence of free AmB in the self-associated form reduces the toxicity of AmB to mammalian cells, whereas the presence of monomeric AmB results in the retention of the antifungal activities of these complexes.Amphotericin B (AmB) formulated with deoxycholate and sodium phosphate as Fungizone is highly effective in the treatment of systemic fungal infections, but its usefulness is limited by toxicity to patients (13,31). The toxicity of AmB can be reduced by incorporating it into liposomes (29,30) or by complexing it to various lipids (1,14,32), and in these less toxic formulations, AmB can be given in higher, more effective doses. These formulations have been successful in treating systemic fungal infections in clinical trials (2), but despite current efforts to rationalize the research on AmB delivery systems (17,25,26), the molecular and cellular bases of the differences in the therapeutic efficacies of these lipid-based formulations and that of Fungizone are not completely elucidated.Recently, the therapeutic efficacies of novel formulations of AmB complexed to either egg lecithin and glycocholate (Egam) or to egg lecithin and deoxycholate (Edam) were compared with that of AmB as Fungizone in murine models of candidiasis and cryptococcosis (11). These formulations were nontoxic at doses 80-fold higher than the maximal tolerated doses in mice infected with Candida albicans and 40-fold higher than the maximal tolerated doses in mice infected with Cryptococcus neoformans. At these doses, Egam and Edam were therapeutically more effective in both models of infection than Fungizone given at maximal tolerated doses.The present study was designed to gain insights into the cellular and molecular bases of the different effects of AmB as Fungizone or complexed with egg lecithin and bile salt. To this end, we characterized the physical states of AmB dispersed in buffer as Fungizone, Egam, or Edam. AmB has characteristic absorption and circular dichroism (CD) spectra (5,12,15), and from spectral analyses of the various formulations, we were able to obtain information about the time and concentration * Corresponding author. Preparation of Egam and Edam...